A detailed history of Arch Venture Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Arch Venture Management, LLC holds 4,834,653 shares of BEAM stock, worth $139 Million. This represents 71.21% of its overall portfolio holdings.

Number of Shares
4,834,653
Previous 5,443,039 11.18%
Holding current value
$139 Million
Previous $128 Million 7.12%
% of portfolio
71.21%
Previous 74.72%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.57 - $33.14 $13.7 Million - $20.2 Million
-608,386 Reduced 11.18%
4,834,653 $118 Million
Q2 2024

Aug 14, 2024

BUY
$21.22 - $32.66 $116 Million - $178 Million
5,443,039 New
5,443,039 $128 Million

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.03B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Arch Venture Management, LLC Portfolio

Follow Arch Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arch Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arch Venture Management, LLC with notifications on news.